Deborah Lycett
The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study
Lycett, Deborah; Nichols, Linda; Ryan, Ronan; Farley, Amanda; Roalfe, Andrea; Mohammed, Mohammed A.; Szatkowski, Lisa; Coleman, Tim; Morriss, Richard K.; Farmer, Andrew; Aveyard, Paul
Authors
Linda Nichols
Ronan Ryan
Amanda Farley
Andrea Roalfe
Mohammed A. Mohammed
LISA SZATKOWSKI LISA.SZATKOWSKI@NOTTINGHAM.AC.UK
Associate Professor
TIM COLEMAN tim.coleman@nottingham.ac.uk
Professor of Primary Care
Richard K. Morriss
Andrew Farmer
Paul Aveyard
Abstract
Background
Smoking increases the risk of developing type 2 diabetes. However, several population studies also show a higher risk in people 3–5 years after smoking cessation than in continuing smokers. After 10–12 years the risk equates to that of never-smokers. Small cohort studies suggest diabetes control deteriorates temporarily during the first year after quitting. We examined whether or not quitting smoking was associated with altered diabetes control in a population study, for how long this association persisted, and whether or not this association was mediated by weight change.
Methods
We did a retrospective cohort study (Jan 1, 2005, to Dec 31, 2010) of adult smokers with type 2 diabetes using The Health Improvement Network (THIN), a large UK primary care database. We developed adjusted multilevel regression models to investigate the association between a quit event, smoking abstinence duration, change in HbA1c, and the mediating effect of weight change.
Findings
10 692 adult smokers with type 2 diabetes were included. 3131 (29%) quit smoking and remained abstinent for at least 1 year. After adjustment for potential confounders, HbA1c increased by 0·21% (95% CI 0·17–0·25; p<0·001; [2·34 mmol/mol (95% CI 1·91–2·77)]) within the first year after quitting. HbA1c decreased as abstinence continued and became comparable to that of continual smokers after 3 years. This increase in HbA1c was not mediated by weight change.
Interpretation
In type 2 diabetes, smoking cessation is associated with deterioration in glycaemic control that lasts for 3 years and is unrelated to weight gain. At a population level, this temporary rise could increase microvascular complications.
Citation
Lycett, D., Nichols, L., Ryan, R., Farley, A., Roalfe, A., Mohammed, M. A., Szatkowski, L., Coleman, T., Morriss, R. K., Farmer, A., & Aveyard, P. (2015). The association between smoking cessation and glycaemic control in patients with type 2 diabetes: a THIN database cohort study. Lancet Diabetes and Endocrinology, 3(6), https://doi.org/10.1016/S2213-8587%2815%2900082-0
Journal Article Type | Article |
---|---|
Publication Date | Jun 1, 2015 |
Deposit Date | Feb 11, 2016 |
Publicly Available Date | Feb 11, 2016 |
Journal | Lancet Diabetes & Endocrinology |
Print ISSN | 2213-8587 |
Electronic ISSN | 2213-8595 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 3 |
Issue | 6 |
DOI | https://doi.org/10.1016/S2213-8587%2815%2900082-0 |
Public URL | https://nottingham-repository.worktribe.com/output/983404 |
Publisher URL | http://dx.doi.org/10.1016/S2213-8587(15)00082-0 |
Additional Information | Copyright Elsevier 2015 |
Files
smoking cessation and glycaemic control.pdf
(605 Kb)
PDF
You might also like
Characterizing tobacco control mass media campaigns in England
(2013)
Journal Article
Smoking cessation advice recorded during pregnancy in United Kingdom primary care
(2014)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search